TMA Navigator: network inference, patient stratification and survival analysis with tissue microarray data

Tissue microarrays (TMAs) allow multiplexed analysis of tissue samples and are frequently used to estimate biomarker protein expression in tumour biopsies. TMA Navigator (www.tmanavigator.org) is an open access web application for analysis of TMA data and related information, accommodating categorical, semi-continuous and continuous expression scores. Non-biological variation, or batch effects, can hinder data analysis and may be mitigated using the ComBat algorithm, which is incorporated with enhancements for automated application to TMA data. Unsupervised grouping of samples (patients) is provided according to Gaussian mixture modelling of marker scores, with cardinality selected by Bayesian information criterion regularization. Kaplan–Meier survival analysis is available, including comparison of groups identified by mixture modelling using the Mantel-Cox log-rank test. TMA Navigator also supports network inference approaches useful for TMA datasets, which often constitute comparatively few markers. Tissue and cell-type specific networks derived from TMA expression data offer insights into the molecular logic underlying pathophenotypes, towards more effective and personalized medicine. Output is interactive, and results may be exported for use with external programs. Private anonymous access is available, and user accounts may be generated for easier data management.

[1]  David R. Westhead,et al.  TmaDB: a repository for tissue microarray data , 2005, BMC Bioinformatics.

[2]  N. Jamieson,et al.  Tissue Biomarkers for Prognosis in Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-analysis , 2011, Clinical Cancer Research.

[3]  Xueli Liu,et al.  Statistical Methods for Analyzing Tissue Microarray Data , 2004, Journal of biopharmaceutical statistics.

[4]  D. E. Roberts,et al.  The Upper Tail Probabilities of Spearman's Rho , 1975 .

[5]  D. Rubin,et al.  Maximum likelihood from incomplete data via the EM - algorithm plus discussions on the paper , 1977 .

[6]  J. Yates,et al.  Large-scale analysis of the yeast proteome by multidimensional protein identification technology , 2001, Nature Biotechnology.

[7]  Gary D. Bader,et al.  Cytoscape Web: an interactive web-based network browser , 2010, Bioinform..

[8]  Koen J. F. Verhoeven,et al.  Implementing false discovery rate control: increasing your power , 2005 .

[9]  Jesper Tegnér,et al.  Reverse engineering gene networks using singular value decomposition and robust regression , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[10]  D. Schoenfeld The asymptotic properties of nonparametric tests for comparing survival distributions , 1981 .

[11]  A. Barabasi,et al.  Interactome Networks and Human Disease , 2011, Cell.

[12]  Y. Benjamini,et al.  THE CONTROL OF THE FALSE DISCOVERY RATE IN MULTIPLE TESTING UNDER DEPENDENCY , 2001 .

[13]  K. Kinzler,et al.  Cancer genes and the pathways they control , 2004, Nature Medicine.

[14]  D. Allred,et al.  Prognostic and predictive factors in breast cancer by immunohistochemical analysis. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[15]  Paul Pavlidis,et al.  The role of indirect connections in gene networks in predicting function , 2011, Bioinform..

[16]  A. Barabasi,et al.  Network medicine : a network-based approach to human disease , 2010 .

[17]  Bernd Lahrmann,et al.  Automatic Tumor-Stroma Separation in Fluorescence TMAs Enables the Quantitative High-Throughput Analysis of Multiple Cancer Biomarkers , 2011, PloS one.

[18]  Ash A. Alizadeh,et al.  Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarrays. , 2002, The American journal of pathology.

[19]  M. Salto‐Tellez,et al.  Reliability of Tissue Microarrays in Detecting Protein Expression and Gene Amplification in Breast Cancer , 2003, Modern Pathology.

[20]  Cheng Li,et al.  Adjusting batch effects in microarray expression data using empirical Bayes methods. , 2007, Biostatistics.

[21]  D. Rimm,et al.  X-Tile , 2004, Clinical Cancer Research.

[22]  E B Cox,et al.  Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors. , 1986, Cancer research.

[23]  Walter Kolch,et al.  Functional proteomics to dissect tyrosine kinase signalling pathways in cancer , 2010, Nature Reviews Cancer.

[24]  S Detre,et al.  A "quickscore" method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas. , 1995, Journal of clinical pathology.

[25]  P. Sham,et al.  Multiple testing and power calculations in genetic association studies. , 2011, Cold Spring Harbor protocols.

[26]  E. Petricoin,et al.  Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front , 2001, Oncogene.

[27]  David Venet,et al.  Most Random Gene Expression Signatures Are Significantly Associated with Breast Cancer Outcome , 2011, PLoS Comput. Biol..

[28]  J. Rao,et al.  Protein expression analysis using quantitative fluorescence image analysis on tissue microarray slides. , 2002, BioTechniques.

[29]  Jim Davies,et al.  A metadata-aware application for remote scoring and exchange of tissue microarray images , 2013, BMC Bioinformatics.

[30]  Igor Goryanin,et al.  Systems biology reveals new strategies for personalizing cancer medicine and confirms the role of PTEN in resistance to trastuzumab. , 2009, Cancer research.

[31]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[32]  E. Lander,et al.  Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. , 2008, Cancer research.

[33]  Ian Abramson On Bandwidth Variation in Kernel Estimates-A Square Root Law , 1982 .

[34]  Johan Lindberg,et al.  Correlation Network Analysis for Data Integration and Biomarker Selectionw , 2007 .

[35]  N. Mantel Evaluation of survival data and two new rank order statistics arising in its consideration. , 1966, Cancer chemotherapy reports.

[36]  M. Takeichi,et al.  Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. , 1993, Cancer research.

[37]  T G Clark,et al.  Survival Analysis Part I: Basic concepts and first analyses , 2003, British Journal of Cancer.

[38]  Kakajan Komurov,et al.  Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes , 2010, Proceedings of the National Academy of Sciences.

[39]  J. Kononen,et al.  Tissue microarrays for high-throughput molecular profiling of tumor specimens , 1998, Nature Medicine.

[40]  Martina Uray,et al.  TAMEE: data management and analysis for tissue microarrays , 2007, BMC Bioinformatics.

[41]  Julio R. Banga,et al.  Inference of complex biological networks: distinguishability issues and optimization-based solutions , 2011, BMC Systems Biology.

[42]  David L Rimm,et al.  Quantitative analysis of breast cancer tissue microarrays shows that both high and normal levels of HER2 expression are associated with poor outcome. , 2003, Cancer research.

[43]  R. Huang,et al.  Epithelial-Mesenchymal Transitions in Development and Disease , 2009, Cell.

[44]  J. Cuzick,et al.  Prognostic Value of a Combined ER, PgR, Ki67, HER2 Immunohistochemical (IHC4) Score and Comparison with the GHI Recurrence Score – Results from TransATAC. , 2009 .

[45]  Joshua M. Stuart,et al.  A Gene Expression Map for Caenorhabditis elegans , 2001, Science.

[46]  D. Rimm,et al.  A decade of tissue microarrays: progress in the discovery and validation of cancer biomarkers. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[47]  G. Schwarz Estimating the Dimension of a Model , 1978 .

[48]  D. Harrison,et al.  Two possible mechanisms of epithelial to mesenchymal transition in invasive ductal breast cancer , 2011, Clinical & Experimental Metastasis.

[49]  M. Rosenblatt Remarks on Some Nonparametric Estimates of a Density Function , 1956 .

[50]  Alberto Riva,et al.  Internet-based profiler system as integrative framework to support translational research , 2005, BMC Bioinformatics.

[51]  David M. Simcha,et al.  Tackling the widespread and critical impact of batch effects in high-throughput data , 2010, Nature Reviews Genetics.

[52]  D. Rimm,et al.  Automated quantitative analysis (AQUA) of in situ protein expression, antibody concentration, and prognosis. , 2005, Journal of the National Cancer Institute.

[53]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[54]  R. Meehan,et al.  An In Vitro Model That Recapitulates the Epithelial to Mesenchymal Transition (EMT) in Human Breast Cancer , 2011, PloS one.

[55]  D. Rimm,et al.  Validation of Tissue Microarray Technology in Breast Carcinoma , 2000, Laboratory Investigation.